Sign Up to like & get
recommendations!
0
Published in 2021 at "Dermatology and Therapy"
DOI: 10.1007/s13555-021-00501-3
Abstract: Determining optimal treatment for moderate plaque psoriasis can be challenging. Recent studies have demonstrated the effectiveness of calcipotriol and betamethasone dipropionate (Cal/BD) foam in patients with moderate-to-severe plaque psoriasis. This research explored the use of…
read more here.
Keywords:
beyond mild;
dermatology;
foam;
treatment ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2024 at "Dermatology and Therapy"
DOI: 10.1007/s13555-024-01108-0
Abstract: Plaque psoriasis is a chronic relapsing inflammatory skin disease that is associated with extensive disease burden that often requires long-term therapy. Treatment of psoriasis with 4 weeks of the aerosol foam formulation of calcipotriol/betamethasone dipropionate…
read more here.
Keywords:
treatment;
hoc analysis;
cal foam;
psoriasis ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Journal of Dermatological Treatment"
DOI: 10.1080/09546634.2022.2095330
Abstract: Abstract Background and objectives Once-daily, fixed-combination calcipotriol 50 μg/g (Cal) plus betamethasone dipropionate 0.5 mg/g (BD) is available in aerosol foam and cream formulations. As no head-to-head data are available, we use a matching-adjusted indirect comparison (MAIC)…
read more here.
Keywords:
cream;
cal cream;
cal foam;
treatment ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Journal of the European Academy of Dermatology and Venereology"
DOI: 10.1111/jdv.17084
Abstract: Real‐world evidence studies are becoming increasingly important in providing insight into clinical effectiveness and safety, economic outcomes, patient‐reported outcomes and health‐related quality of life of treatments in the clinical setting. These studies also help to…
read more here.
Keywords:
real world;
foam;
efficacy;
cost effective ... See more keywords